Recent studies showed that germ-free (GF) mice are resistant to obesity when consuming a high-fat, high-carbohydrate Western diet. However, it remains unclear what mechanisms are involved in the antiobesity phenotype and whether GF mice develop insulin resistance and dyslipidemia with high-fat (HF) feeding. In the present study, we compared the metabolic consequences of HF feeding on GF and conventional (conv) C57BL/6J mice. GF mice consumed fewer calories, excreted more fecal lipids, and weighed significantly less than conv mice. GF/HF animals also showed enhanced insulin sensitivity with improved glucose tolerance, reduced fasting and nonfasting insulinemia, and increased phospho-Akt (Ser-473) in adipose tissue. In association with enhanced insulin sensitivity, GF/HF mice had reduced plasma TNF-␣ and total serum amyloid A concentrations. Reduced hypercholesterolemia, a moderate accretion of hepatic cholesterol, and an increase in fecal cholesterol excretion suggest an altered cholesterol metabolism in GF/HF mice. Pronounced nucleus SREBP2 proteins and up-regulation of cholesterol biosynthesis genes indicate that enhanced cholesterol biosynthesis contributed to the cholesterol homeostasis in GF/HF mice. Our results demonstrate that fewer calorie consumption and increased lipid excretion contributed to the obesityresistant phenotype of GF/HF mice and reveal that insulin sensitivity and cholesterol metabolism are metabolic targets influenced by the gut microbiota.-Rabot, S., Membrez, M., Bruneau, A., Gérard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R., Chou. C. J. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 24, 4948 -4959 (2010). www.fasebj.org
Since the reproduction of germ-free (GF) rats in an isolator was established, the ability to maintain and reproduce GF animals has allowed scientists to address questions related to the gut microbiota. Recently, GF mice have been used to study the effects of the intestinal microbiota on obesity and metabolic energy balance. Bäckhed et al. (1, 2) showed that GF C57BL/6J mice gained less weight than conventional (conv) mice when consuming a chow or a sugar and fat-rich Western diet, but the mechanisms explaining the obesity resistant phenotype of GF mice are not clear. Existing data show that food intake and total fecal calorie were similar in GF and conv mice on the Western diet (2), but these results were observed in a small number of GF animals. In addition, fecal caloric values determined by bomb calorimetry are not suitable for comparing energy excretion of GF and conv mice because the energy contribution from bacteria mass and mucins to total fecal calories is largely different between the 2 groups. Therefore, further studies are needed to examine whether food intake and energy excretion in feces contribute to obesity resistance of GF mice.
In association with an excessive weight gain, Western diet feeding affected the cecal microbiota by increasing Firmicutes and reducing Bacteroidetes in conv C57BL/6J mice (3) . In particular, propagation of Erysipelotrichi, a class of Firmicutes, was significantly pronounced in cecal microbiota of Western diet-associated animals (3, 4) . Functionally, the Western diet-associated intestinal metagenome is characterized by enrichment of bacterial genes involved in the transport and fermentation of simple sugars and host glycans (3) . It has been hypothesized that the ability of intestinal bacteria to ferment dietary fibers can lead to an increase in the production of short chain fatty acids, which contributes to weight gains observed in obese mice (5) . In addition to inducing obesity, high-fat (HF) feeding also leads to insulin resistance in mice, but the role of the gut microbiota in diet-induced insulin resistance has not been fully explored. Recently, Larsen et al. (6) reported that the fecal microbiota composition differs between type 2 diabetic subjects and healthy volunteers. In addition, a number of publications (7, 8) have demonstrated that antibiotic administration improves oral glucose tolerance in ob/ob and HF diet-induced insulin resistant C57BL/6J mice. These data suggest that not only a gut microbiota profile is associated with insulin resistance but that modulation or reduction of the gut microbiota can be a successful strategy in managing insulin resistance. Another consequence of HF feeding is the development of dyslipidemia. In conv C57BL/6J mice, chronic HF feeding induces the expression of hepatic HMG-CoA reductase (HMGCR) mRNA (9, 10) , increases liver HMGCR activity, and enlarges cholesterol storage (9) . However, it is not clear whether GF mice would respond to long-term HF feeding in a similar way to conv mice by increasing their cholesterol biosynthesis.
In the present study, we examined the effects of the GF condition on the development of obesity, insulin resistance, and dyslipidemia in mice fed a sterilized HF diet. Transcriptional profiling of hepatic genes was compared to reveal different metabolic adaptations of GF and conv mice to a HF diet. Results from our study suggest that lack of gut microbiota prevents diet-induced obesity by reducing food intake and increasing fecal lipid outputs. Lack of commensal gut microbiota also affected the development of diet-induced insulin resistance and introduced multiple changes in cholesterol metabolism in C57BL/6J mice.
MATERIALS AND METHODS

Animal experimentation
Fourteen GF male C57BL/6J mice were reared from GF breeding pairs in GF isolators at Institut National de la Recherche Agronomique in Micalis Germfree Rodent Facilities (ANAXEM, Jouy-en-Josas, France). In parallel, 16 conventional male C57BL/6J mice were ordered from Charles River Laboratories (L'Arbresle, France). All mice were housed individually and received a sterile rodent chow diet (R03; SAFE, Augy, France) and water ad libitum. At 6 wk of age, a sterilized HF diet [D12492 with 60% energy from fat and 0.03% w/w cholesterol (Research Diets, New Brunswick, NJ, USA) sterilized with ␥-irradiation 25 kGy] was introduced for an additional 11 wk. Both GF and conv mice were kept in the same room to ensure comparable conditions. Body weight and diet consumption of mice were measured weekly. Spillage of food pellets on the bottom of the cage was carefully collected to ensure the quality of food intake measurements. Mice were deprived of food for 6 h before an oral glucose tolerance test (OGTT). At 2 h after completing the OGTT, all mice were killed with an overdose of isoflurane (Aerrane; Baxter, Maurepas, France). White (epididymal, mesenteric, and retroperitoneal) adipose tissues, liver, total gut, and cecum content were collected immediately after exsanguination and flash-frozen in liquid nitrogen. Procedures were carried out in accordance with the European Guidelines for the Care and Use of Laboratory Animals and with permission 78-63 of the French Veterinary Services.
OGTT
The OGTT was performed after 6 h food deprivation at the end of HF diet feeding. Blood glucose concentrations were analyzed from tail vein samples using an Ascensia Elite XL glucometer (Bayer AG, Zurich, Switzerland), before (time 0 min) and at 15, 30, 60, and 120 min after the animals were given a glucose solution at 2 g/kg body weight (BW) by oral gavage. Samples collected at 0, 15, and 120 min were put into chilled EDTA-coated tubes for insulin determination.
Measurements of plasma parameters
Blood taken from the vena cava at death was collected into chilled EDTA-coated tubes and centrifuged at 2000 rpm for 10 min. Plasma was aliquoted and frozen at Ϫ80°C until it was analyzed. Plasma samples were analyzed for triglycerides (Roche Diagnostics, Basel, Switzerland), free fatty acids (Wako, Neuss, Germany), insulin (IBL, Hamburg, Germany), total cholesterol (Roche Diagnostics), HDL-cholesterol (Biovision Research, Mountain View, CA, USA), serum amyloid A (SAA; Invitrogen Corp., San Diego, CA, USA), and leptin (Linco Research, St. Charles, MO, USA) concentrations with commercial kits. The plasma proinflammatory cytokines IFN␥, IL-10, IL-1␤, IL-6, and TNF-␣ were measured by immunoassay with electrochemiluminescence detection (Meso Scale Discovery, Gaithersburg, MD, USA) according to the manufacturer's instructions.
Measurement of fecal and liver lipids
Fecal pellets from individual GF/HF mice were pooled to have sufficient material for analysis. For conv/HF and conv/ chow mice, each pool consisted of fecal pellets from 12 individuals. Lyophilized feces (150 mg) was used for lipid extraction according to Hara and Radin (11) . Total cholesterol (Roche Diagnostics), triglyceride (Roche Diagnostics), and free fatty acid (Wako) concentrations were quantified using commercial kits. For triglyceride measurements, lipids were first hydrolyzed in a basic solution (0.5 N KOH in ethanol). For the determination of liver triglyceride and cholesterol concentrations, 200 mg frozen liver was used to extract lipids according to Folch et al. (12) . Total cholesterol and triglycerides were quantified as above. Results were then normalized to the weight of the sample.
Measurement of liver glycogen
Frozen liver (50 -100 mg) was incubated in 30% KOH solution for 15-30 min in a boiling water bath. After homogenization, glycogen was precipitated with 96% ethanol, followed by centrifugation at 5000 rpm for 10 min. Pellets were resuspended in 1 ml distilled water for the amyloglucosidase digestion. Samples (200 l) were incubated in 1.8 ml of lyophilized amyloglucosidase dissolved in acetate buffer (0.2 M, pH 4.8 at a final concentration of 10 U/ml) for 2 h at 40°C. The resulting glucose solution was then measured with a Quantichrom glucose assay kit (BioAssay Systems, Hayward, CA, USA). Results were then normalized to the weight of the sample.
Western blot
Frozen epididymal adipose tissues were homogenized in tubes containing Lysing matrix D (MP Biomedicals, Illkirch, France) and an ice-cold buffer A (10 mM KHEPES, pH 7.9; 10 mM KCl; 1.5 mM MgCl 2 ; 0.5 mM DTT; 1 mM PMSF; and protease inhibitor cocktail tablets; Roche). The homogenates were centrifuged at 14,000 rpm for 10 min at 4°C before the protein concentration was measured. The purified protein fractions were stored at Ϫ80°C before Western blotting. Frozen livers were pulverized in liquid nitrogen and incubated in buffer A for 20 min. The samples were homogenized with a Polytron PT1300D (Kinematica AG, Lucerne, Switzerland) for 10 s at medium speed and centrifuged at 4000 rpm for 3 min at 4°C. The supernatant containing the cytosolic fraction was kept in a prechilled tube. The pellet was resuspended in ice-cold buffer B (20 mM KHEPES, pH 7.9; 400 mM NaCl; 1.5 mM MgCl 2 ; 0.5 mM DTT; 0.2 mM EDTA; 1 mM PMSF; and protease inhibitor cocktail tablets) and was gently rotated for 20 min at 4°C. The samples were then centrifuged at 14,000 rpm for 10 min at 4°C. Total protein concentration of each sample was determined using a BCA protein assay kit (Pierce, Rockford, IL, USA). For Western blot analysis, 50 g of protein was loaded into a 12-well Invitrogen NuPAGE Novex 10% Bis-Tris gel for separation by electrophoresis and then transferred to a nitrocellulose membrane as indicated in the manufacturer's instructions (Invitrogen). Primary antibodies, rabbit polyclonal anti-SREBP2 (NB100-74543; Novus Biological, Littleton, CO, USA), rabbit polyclonal anti-␤-actin (Invitrogen), and rabbit polyclonal anti-Akt and anti-phospho-Akt (Ser-473; Cell Signaling Technology, Inc., Danvers, MA, USA) were incubated at 4°C overnight, followed by secondary horseradish perioxidase-anti-rabbit antibody (Invitrogen) incubation. The blots were visualized with BM chemiluminescence Western blot kit (Roche).
Gene expression analysis by microarray
Liver samples (10 mg) were homogenized in lysis buffer, using a FastPrep instrument, in lysing tubes containing ceramic beads (MP Biomedicals, Irvine, CA, USA). Total RNA was extracted and purified with the RNAdvance tissue kit (Agencourt, Beverly, MA, USA) using an automated procedure on a robotic station. The quality of RNA samples was checked by using the Agilent 2100 Bioanalyser (RNA integrity numbers Ն8 for high quality; Agilent Technologies, Santa Clara, CA, USA). All cRNA targets were synthesized, labeled, and purified according to the Illumina TotalPrep RNA amplification protocol (Applied Biosystems/Ambion, Austin, TX, USA), using an automated procedure that has been adapted to the Illumina procedure. Then, 15 l of each hybridization mix was dispensed on the arrays. After overnight hybridization (16 h, 58°C), the arrays were washed to remove nonhybridized material and stained with Streptavidin-Cy3, which binds with biotin. All samples were analyzed with MouseRef-8 v1.1 Expression BeadChips (Illumina, San Diego, CA, USA). Scanning was performed using a BeadArray Reader (Illumina). Absolute signal intensities were extracted and summarized in the BeadStudio software (Illumina). Data were quantile normalized, and log2 transformations were made using Partek software (St. Louis, MO, USA). Microarray data files have been deposited in GEO Omnibus (http:// www.ncbi.nlm.nih.gov/geo/) with the accession number GSE19038. Quality control of the data was performed on all samples with a Pearson correlation matrix and a principal component analysis on all probes. To assess which probes were differentially expressed between the GF/HF and the conv/HF groups, 1-way ANOVA was performed, followed by a global error assessment (GEA; ref. 13 ). The GEA results in a robust MSE that replaces the current MSE from the classical ANOVA; a new F statistic is recalculated, and a robust P value is derived. A list of probes was then selected, based on their P value (cutoff PϽ0.001) and their fold change, taken to be Ͼ1.3 or ϽϪ1.3 between the 2 groups. Selected probes, along with their differential expression value, were loaded into the Ingenuity Pathways Analysis software (IPA; Ingenuity Systems; http:// www.ingenuity.com) for annotation, redundancy checks, and network and pathway analysis, with the following criteria: reference set, MouseRef-8 v1.1; direct and indirect relationships included. Semantic relationship analysis with IPA software generated significant networks of genes that are wellcharacterized metabolic and cell-signaling pathways as documented in published articles and books and the KEGG Ligand database, with the satisfaction of the right-tailed Fisher's exact test.
Gene expression analysis by quantitative PCR
Reverse transcription was performed on 1.5 g total RNA using the first-strand cDNA synthesis kit for real-time PCR (AMV; Roche Biomedical) with oligo d(T) 15 as primer. Real-time PCR analyses were performed in a fluorescent temperature cycler (GeneAmp PCR 5700 Sequence Detection System; Applied Biosystems). Values were normalized to GAPDH expression. The effects of treatments on gene expression were evaluated by calculating the relative expression level of each gene of interest) (GOI) as follows: 2
, using the mean raw cycle-threshold (C t ) values.
Statistical analyses of biological data
All biological parameters were tested by Wilcoxon tests due to the presence of outliers or abnormally distributed data. Results are presented as medians Ϯ se. The se was computed using a robust sd based on Sn of Rousseeuw (14) . All tests were performed 2-sided. Analysis was performed with R 2.6.1 (15) .
RESULTS
GF mice are resistant to diet-induced obesity
All male GF C57BL/6J mice were reared from GF breeding pairs residing in isolators. At 6 wk old, a sterile HF diet was provided ad libitum to GF (GF/HF) and conv (conv/HF) mice for 11 wk. The GF status of mice was monitored weekly by culturing fresh fecal samples in aerobic and anaerobic conditions; none of the fecal samples from GF mice contained replicating bacteria (Supplemental Table S1 ). BW of GF and conv mice on the HF diet are shown in Fig. 1A and Table 1 . In contrast to the age-matched conv/HF male mice who gained 15.0 Ϯ 1.1 g BW in 11 wk, GF/HF mice only gained 5.3 Ϯ 0.9 g (PϽ0.001). Epididymal (3.5-fold), mesenteric (3.6-fold), and retroperitoneal (4.7-fold) fat pads also weighed less in GF/HF than in conv/HF mice ( Table 1) . As expected, plasma leptin concentrations were lower in GF/HF mice ( Table 2) . Cecum weight was 11-fold greater in GF/HF than in conv/HF mice (Table 1) , which is one of the hallmark features of GF rodents.
GF mice have reduced food intake and increased fecal lipid excretion
Food intake of individual mice was measured weekly. The cumulated food intakes of GF/HF and conv/HF mice are illustrated in Fig. 1B . GF mice ate 16% less food than conv controls in 11 wk, and the difference was statistically significant (168.0Ϯ4.2 vs. 200.5Ϯ3.7 g; PϽ0.001). When food intake of each mouse was normalized to its BW or metabolic mass (BW 0.75 ), GF mice still consumed less of the HF diet than their conv counterparts (Fig. 1C) . In addition, food efficiency was reduced by 54% in GF/HF mice (Fig. 1D) , indicating that these mice are inefficient in converting dietary energy into body mass. To examine the possible reasons for the reduction in food efficiency, fecal lipids were measured in GF/HF and conv/HF mice. Fecal samples collected from conv C57BL/6J mice fed a standard chow diet were used as a reference. Feces of GF/HF mice contained 40% more total lipids than that of conv/HF mice ( Fig. 2A) . When the lipid composition of the feces was compared, a trend for high triglycerides (Fig. 2B ) and significantly more cholesterol ( Fig. 2C) but not fecal free fatty acids (Fig. 2D ) was observed in GF/HF group. Our data indicate that GF mice are resistant to HF-diet-induced obesity and that reduced food intake together with increased fecal lipid output contributes to the lean phenotype of GF/HF mice.
GF mice are resistant to diet-induced insulin resistance
C57BL/6J mice develop obesity and insulin resistance when fed an HF diet, and insulin resistance of DIO mice can be improved by reducing the gut microbiota using antibiotics (8) . To study whether the gut microbiota is required for diet-induced insulin resistance, parameters indicating insulin sensitivity were measured in GF/HF and conv/HF mice. When compared with GF/HF mice, elevation of blood glucose in conv/HF mice was apparent after 6 h of food deprivation but not in a fed state (Fig. 3A) . Plasma insulin concentrations were lower in GF/HF mice than in conv/HF controls in both the 6 h unfed and fed states (Fig. 3B) . To further examine the insulin sensitivity of mice, OGTT were conducted at the end of the study. As illustrated in Fig.  3C , conv/HF mice developed glucose intolerance as expected, whereas GF/HF mice showed improved blood glucose clearance with reduced baseline and ). D) Food efficiency. Data are medians Ϯ se; n ϭ 14 for GF/HF, n ϭ 16 for conv/HF mice. *P Ͻ 0.05; Wilcoxon test peak glycemia. Enhanced glucose tolerance in GF/HF mice was accompanied by reduced insulin concentrations during the OGTT (Fig. 3D) . To examine whether the adipose tissue of GF/HF mice was more insulin sensitive, phosphorylation of Akt (also known as protein kinase B) on Ser-473 was determined. As shown in Fig. 4A , enhanced p-Akt (Ser-473) was evident in the epididymal adipose tissue of GF/HF mice. Together with the observed reduction in unfed-state glycemia and insulinemia, these results indicate that GF mice were resistant to HF diet-induced insulin resistance. Next, we determined liver glycogen concentrations in GF/HF and conv/HF mice after 10 h food deprivation. In this condition, liver glycogen storage was lower in GF/HF (0.939Ϯ0.526 mg/g liver) than in conv/HF mice (6.152Ϯ2.835 mg/g liver; Pϭ0.038), whereas the expression of hepatic G6PC mRNA was 2-fold higher in GF/HF than in conv/HF mice ( Table 3) .
Low-grade inflammation is commonly associated with obesity and insulin resistance. To characterize the state of systemic inflammation in GF/HF and conv/HF mice, we measured the mRNA expression of proinflammatory cytokines in epididymal adipose tissue and their protein concentrations in plasma. The mRNA of TNF-␣ (Ϫ3.12-fold; Pϭ0.09), IL-6 (Ϫ4.27-fold; Pϭ0.08), and IL-1␤ (Ϫ2.43-fold; Pϭ0.12) was lower in the GF/HF than in the conv/HF group, but the differences were not statistically significant. Similarly, plasma IL-1␤ and IL-6 concentrations in the GF/HF group were lower, but they were not statistically significant. However, plasma TNF-␣ concentrations were significantly lower in GF/HF than in conv/HF mice ( Table 2 ). In addition, antibacterial IFN␥ and the antiinflammatory cytokine, IL-10, were also lower in GF/HF mice.
Lipid metabolism is affected by the GF condition
To evaluate the role of the gut microbiota on lipid metabolism, the plasma lipid profiles of GF/HF and conv/HF mice were examined. At 10 h of food deprivation, GF/HF mice had reduced plasma free fatty acid (Fig. 5A ) and triglyceride concentrations (Fig. 5B ) when compared with conv/HF mice. In addition, the amount of liver triglyceride was also lower in GF/HF than in conv/HF mice (Fig. 5C) . To investigate the regulation of hepatic lipid metabolism in GF/HF mice, the expression of lipogenic genes was assessed using RT-PCR. In association with reduced plasma and hepatic triglycerides, downregulation of peroxisome proliferator activated re- 
. Plasma leptin and inflammatory markers of the GF/HF and the conv/HF mice
Type Leptin (ng/ml) IFN␥ (pg/ml) IL-10 (pg/ml) IL-1␤ (pg/ml) IL-6 (pg/ml) TNF-␣ (pg/ml) SAA (g/ml) Data are medians Ϯ se; n ϭ 10 except for leptin and SAA, n ϭ 14 GF/HF, and n ϭ 16 conv/HF. *P Ͻ 0.05; Wilcoxon test.
ceptor-␥ (PPAR␥) and stearoyl-CoA desaturase 1 (SCD1) mRNA was found in the liver of GF/HF mice ( Table 3) . As illustrated in Fig. 5D , E, GF/HF mice had reduced plasma total cholesterol and HDL cholesterol concentrations when compared with the conv/HF controls. However, a moderate elevation in liver cholesterol (Fig.  5F ) and a 2.8-fold increase in hepatic HMGCR mRNA expression (Table 3) were found in GF/HF mice. To study whether SREBP2 was involved in the transcriptional control of the HMGCR gene, we measured the protein quantity of SREBP2 in different subcellular fractions of the liver by Western blots. As illustrated in Fig. 4B , nuclear SREBP2 was higher in liver of GF/HF than of conv/HF mice, whereas cytosolic SREBP2 proteins were similar in both groups. Our data indicate that the accumulation of liver cholesterol in GF/HF mice is associated with an increased ability to synthesize cholesterol.
Comparison of global gene expression in the liver of GF/HF and conv/HF mice
To reveal the effect of the GF condition on liver metabolism, we performed a transcriptomic analysis with the livers of GF/HF (nϭ14) and conv/HF (nϭ16) mice. A total of 236 differentially regulated unique transcripts were identified based on a cutoff of P Ͻ 0.001 and Ն1.3-fold change; 121 transcripts were up-regulated and 115 transcripts were downregulated in the liver of GF/HF mice. The most overrepresented canonical pathways and the proportions of differentially regulated genes in these pathways are shown in Fig. 6A . Many of the most overrepresented canonical pathways are defensive mechanisms that respond to environmental stimulations. For example, pathways related to the metabolism of xenobiotics, such as PXR/RXR activation and cytochrome P450 pathways, as well as pathways that react against bacterial components, such as LPS-1/ IL-1-mediated inhibition of RXR function, were overrepresented in the liver of GF/HF mice. Complement factor D (CFD, Ϫ3.33-fold), hepcidin antimicrobial peptide 1 (HAMP, Ϫ2.32-fold), serum amyloid A1 (SAA1, Ϫ2.06-fold) and lipocalin 2 (LCN2, Ϫ2.06-fold) were among the most downregulated molecules in GF/HF mice (Supplemental Table S2 ), further indicating that many components of the innate immune system in mice were reduced in a GF condition. Expression of HAMP, SAA1, and LCN2 is a part of acute-phase responses. Recent data suggested that a high amount of SAA proteins causes insulin resistance in 3T3-L1 adipocytes (16) . In the present study, plasma total SAA concentrations were lower in GF/HF than in conv/HF mice (Table 2 ) and the data is in accordance with improved glucose tolerance in GF/HF mice (Fig. 3C) .
Biosynthesis of steroids is another overrepresented canonical pathway. Unlike other pathways, all differentially regulated genes, such as HMG-CoA synthase 1 (HMGCS1, 2.15-fold), HMGCR (1.47-fold), farnesyl Data are median Ϯ se expression (2 Ϫ⌬⌬Ct ); n ϭ 6 for G6Pc, PPAR␥, and HMGCR or n ϭ 12 for SCD1, ABCG5, and ABCG8. Samples were collected after 10 h food deprivation. Expression of target genes was normalized to the level of GAPDH. For, forward; Rev. reverse. *P Ͻ 0.05; Wilcoxon test. diphosphate synthase (FDPS, 1.94-fold), squalene epoxydase (SQLE, 2.77-fold), and 7-dehydrocholesterol reductase (DHCR7, 1.47-fold), were up-regulated in GF/HF mice (Supplemental Table S2 ), and the increase in HMGCR mRNA expression was confirmed with RT-PCR (Table 3 ). Figure 6B illustrates the coregulation of SREBP2 and its target genes based on known semantic relationships. Synergistic up-regulation of Figure 6 . Global gene expression analysis from GF/HF and conv/HF livers. A) Compared with data from the conv/HF group, the 10 most overrepresented canonical pathways in liver from GF/HF mice are illustrated. Total of number of genes in each respective pathway is indicated in parentheses. Up-regulation and down-regulation of genes in each pathway are indicated by red and green bars, respectively. Length of the bar in each direction indicates the proportion of the differentially regulated genes in each specific pathway. Numbers located inside the red or green areas show the number of differentially regulated genes in each respective direction. B) Differentially regulated hepatic genes shown in the GF/HF to conv/HF comparison and their semantic associations to nuclear SREBP2. The darker the red color, the greater the fold change of gene expression. Data were analyzed and the networks were generated through the use of IPA (Ingenuity Systems; www.ingenuity.com).
SREBP2 mRNA, SREBP2 protein in the nuclei, and the SREBP2 target genes suggests that SREBP2 is an important transcriptional factor that controls cholesterol metabolism in a GF condition. Down-regulation of lipogenic genes, including PPAR␥ (Ϫ1.71-fold) and SCD1 (Ϫ1.73-fold), in the liver of GF/HF mice was also observed in the transcriptomic analysis, and the results were confirmed by RT-PCR (Table 3) . Unexpectedly, ATP-binding cassette transporter G5 and G8, the 2 genes involved in reverse cholesterol transport, were up-regulated in GH/HF mice, 1.223-fold and 1.338-fold, respectively. Since the difference is near the level of detection limited by the microarray analysis, we then examined the expression of both genes by RT-PCR. As shown in Table 3 , upregulation of hepatic ABCG5 and ABCG8 in liver of GF/HF mice was confirmed.
DISCUSSION
In the present study, we examined the role of the gut microbiota in diet-induced obesity and insulin resistance. Our results show that the absence of the gut microbiota has profound effects on the development of obesity, glucose regulation, and cholesterol metabolism homeostasis.
Regulation of BW in GR mice fed an HF diet
Previously, Bäckhed et al. (2) reported that GF mice gained less weight on a Western diet than conv mice. Our results agree with their findings and demonstrate that GF C57BL/6J mice are resistant to the development of obesity when consuming an HF diet. In contrast, Fleissner et al. (17) showed that GF C3H mice gained more weight than conv mice when mice consumed an HF diet. The discrepancy of the weight gain between the studies is probably due to the strain of mice used in each study. Future studies comparing the obesity development of different strains of mice are needed to confirm this hypothesis. In the present study, we observed a significant reduction in cumulative food intake by GF mice during the 11-wk feeding period. After normalization to BW or metabolic mass, food consumption was still lower in GF/HF than conv/HF mice. In addition, increased energy excretion in GF mice can explain much of the reduced food efficiency. Although previous data demonstrate that total fecal calories, measured by a bomb calorimeter, are similar in GF and conv mice (2), we observed that total fecal lipids were higher in GF/HF than in conv/HF mice. The reason fecal lipids instead of total fecal calories were measured is because the fecal composition is very different between GF and conv mice. In GF animals, feces contain undigested plant polysaccharides and endogenously produced mucins, which are normally digested and fermented by the bacteria residing in the distal intestine of conv mice, while bacteria mass, an absent component in GF feces, represents a large portion of the calorie content of conv feces. Because of the intrinsic difference in fecal composition between GF and conv mice, we decided to examine the fecal lipid composition to estimate the contribution of energy excretion to energy balance in GF and conv mice. In our experiment, reduced energy intake and enhanced lipid excretion are the two contributing factors that explain the lack of weight gain in GF/HF mice.
Mechanisms of improved insulin sensitivity in GF/HF mice
Here we demonstrate that GF mice are resistant to HF-diet-induced insulin resistance. While reduction in BW and body fat can significantly contribute to enhancing insulin sensitivity in GF/HF mice, absence of the intestinal microbiota may be an independent contributor to whole-body insulin sensitivity. This argument is supported by a recent publication (8) demonstrating that antibiotic treatment reduces the number of cecal bacteria and normalizes glucose tolerance in ob/ob and DIO. However, the molecular mechanisms behind the improved oral glucose tolerance, as well as reduced glycemia and insulinemia, are unknown. Bäckhed et al. (2) have shown that phosphorylation of AMPK is elevated in skeletal muscle of GF mice. Since activation of AMPK has been shown to increase insulin-stimulated glucose transport in ex vivo epitrochlearis muscles (18) , enhanced AMPK activity in muscle can positively influence glucose clearance in GF/HF mice during an OGTT.
Alternatively, many groups, including our own, have suggested that lipopolysaccharides (LPS) absorbed from gram-negative bacteria residing in the intestine may induce insulin resistance in the host (7, 8, 19) . Abrogation of intestinal bacteria, as in the GF condition, should minimize the exposure of GF mice to LPS and avoid LPS-induced insulin resistance. Although the LPS concentration was not measured in the present study, the confirmation of GF status and low plasma TNF-␣ concentrations let us assume that there was little or no LPS in GF/HF mice. When conv/HF mice are considered, infiltration of macrophages into the adipose tissue results in inflammatory responses, with excessive production of proinflammatory cytokines such as TNF-␣ (20) . TNF-␣ has been shown to induce insulin resistance in obese Zucker rats (21) , and its concentration in plasma positively correlates with obesity and insulin resistance in animal models (22) . More important, the fact that insulin sensitivity can be normalized by neutralization of TNF-␣ receptors in obese Zucker rats (22) and by deletion of TNF-␣ in mice (23, 24) clearly demonstrates the causal role of TNF-␣ in insulin resistance. Plasma TNF-␣ concentrations were significantly less in GF/HF than conv/HF mice. Therefore, it is plausible that the ability of GF mice to resist diet-induced insulin resistance is partially due to low plasma TNF-␣ concentrations.
Another hallmark feature of insulin resistance is the inability of insulin to suppress lipolysis in adipocytes. Consequentially, elevated plasma free fatty acid concentrations lead to lipotoxicity and insulin resistance in the liver, skeletal muscle, and pancreas (25) . Recently, Berggreen et al. (26) showed that insulinmediated suppression of lipolysis depends on functional Akt. Inhibition of Akt with a pharmacological inhibitor, Akti, decreased insulin-stimulated phosphorylation of Akt on Thr-308 and Ser-473 and attenuated insulin-mediated antilipolytic effects in isolated rat adipocytes and 3T3-L1 cells (26) . In the present study, decreased phosphorylation of Akt on Ser-473 in adipose tissue and elevated plasma free fatty acid concentrations were found in conv/HF mice, suggesting that their adipose tissue is resistant to elevated basal insulin concentrations after 10 h food deprivation when compared with GF/HF mice who are sensitive to lower concentrations of insulin under the same condition.
Changes of cholesterol metabolism in GF/HF mice
In the present study, moderate elevations in liver cholesterol and marginally reduced plasma total and HDL cholesterols were observed in GF/HF mice, which is in agreement with previous data by Wostmann and Wiech (27) . The moderate increase of liver cholesterol in GF/HF mice can be partially explained by increased cholesterol biosynthesis, as supported by several key observations: overexpression of SREBP2 protein in the nuclei of GF/HF livers, and up-regulation of HMGCS1, HMGCR, FDPS, SQLE, and DHCR7 mRNAs in GF/HF livers. Because the expression of HMGCR mRNA is positively correlated with its enzymatic activity in the liver of C57BL/6J mice (9, 28), it is highly possible that cholesterol biosynthesis is increased in GF/HF mice. In addition to increased endogenous cholesterol production, increased dietary cholesterol absorption and enhanced cholesterol uptake by hepatocytes can contribute to elevated hepatic cholesterol storage. However, the influence of these 2 mechanisms is unlikely, because the cholesterol content of the HF diet was very low (0.03% w/w), and GF/HF mice consumed less food in the present study. Also, mRNA expression of the LDL receptor was similar in GF/HF and conv/HF mice, suggesting that mechanisms other than cholesterol uptake are involved in the homeostasis of cholesterol metabolism in GF/HF mice. We unexpectedly observed a 2-fold increase in fecal cholesterol in GF/HF mice. This observation can be explained by a lack of cholesterol absorption in the intestine or an increase in cholesterol excretion by the liver. The first possibility is unlikely because it contradicts published data demonstrating that GF animals absorb dietary cholesterol more efficiently than conv controls (29) . In support of the second possibility, we found that hepatic ABCG5 and ABCG8 expression was elevated in the GF/HF liver. ABCG5 and ABCG8 are membrane transporters that are expressed primarily in hepatocytes and enterocytes in the proximal small intestine of humans and mice (30) . Functionally, these transporters are important for the excretion of cholesterol in feces via reverse cholesterol transport. Up-regulation of ABCG5/G8 via LXR-mediated activation is required for transporting cholesterols from lipid laden macrophages to HDL particles and then from hepatocytes to the gallbladder in the liver (31) . Overexpression of human ABCG5/G8 in mice results in a 3-fold increase in fecal cholesterols in males when compared with gender matched wild-type littermates (32) . In this transgenic mouse model, an increase in hepatic cholesterol biosynthesis and biliary cholesterol secretion has also been reported (33) . Interestingly, changes of cholesterol metabolism in GF/HF mice are remarkably similar to those of ABCG5/G8 transgenic mice. In both models, a slight increase in liver cholesterol, a mild reduction in plasma cholesterol, and an up-regulation of cholesterol biosynthesis were observed (33). Yu et al. (33) suggested that in ABCG5/G8 transgenic mice the accelerated loss of cholesterol from the body is compensated for by an increase in hepatic cholesterol biosynthesis and that the balance of synthesis and secretion of cholesterol results in mild differences in the plasma and liver cholesterols when compared with wild-type controls.
The reason for the elevated ABCG5/G8 expression in GF/HF mice is not clear. Diminished exposure to intestinal bacteria and bacterial compounds could have positively affected ABCG5/G8 expression. Recently, endotoxemia has been shown to suppress the expression of ABCG5/G8 in the liver and to decrease fecal cholesterol excretion (33) (34) (35) . Under conventional conditions, plasma LPS concentrations are increased in mice fed an HF diet (36) , which supports our observation that ABCG5/G8 mRNA levels were suppressed in the liver of conv/HF mice. In GF conditions, mice are exposed to minimal amounts of bacterial LPS; hence, the mechanism by which LPS inhibits the expression ABCG5/G8 genes is not strongly induced. As a consequence, high hepatic ABCG5/G8 expression was observed, which could explain the very large fecal cholesterol excretion found in the feces of GF/HF mice.
Another possible explanation for elevated fecal cholesterol is the lack of bacterial activity in GF conditions. Under conventional conditions, cholesterol is converted to coprostanol by the gut microbiota (37) . Species in the genus Eubacterium isolated from the cecum of rats (38) and Bacteroides sp strain D8 that is closely related to Bacteroides dorei of human origin (39) have been shown to contain cholesterol reducing activity. In the absence of intestinal bacteria and bacterial activity in GF mice, the conversion of cholesterol to coprostanol would not occur and the composition of fecal steroids would be different. To better understand the role of gut microbiota in the homeostasis of cholesterol metabolism, future studies should examine the physiological effects of intestinal cholesterol conversion by intestinal microbiota and its reabsorption by the host.
Previously, we demonstrated that reduction of intestinal bacteria with an antibiotic treatment improved oral glucose tolerance of ob/ob and DIO mice (8) . In the present study, we confirmed that C57BL/6J mice born and raised in a GF environment are resistant to dietinduced obesity. Reduced food intake and increase fecal lipid excretion contributed to the limited weight gain and decreased food efficiency. In addition, we also demonstrated that GF C57BL/6J mice are resistant to HF feeding associated insulin resistance, hepatic steatosis, dyslipidemia, and elevated systemic proinflammatory markers. More interestingly, GF/HF mice display unexpected changes in cholesterol metabolism with synergistic elevation of hepatic SREBP2 mRNA and protein levels in the nuclei as well as the expression of SREBP2 target genes in the cholesterol biosynthesis pathway. In summary, the results of this study reveal many fundamental differences in the physiology of GF mice and demonstrate the importance of intestinal bacteria in the regulation of lipid and carbohydrate metabolism of the host.
